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razolo[1,5-a]quinoline-4-yl)methylidene]}-2-[(4-substitutedphenyl)amino]-1,3-thiazol-4(5H)-one
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Structures of these newly synthesized compounds were established on the basis of spectral and ana-
lytical data. These novel compounds were also evaluated for their in vitro antioxidant, antibacterial
and antifungal activity.
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The derivatives of 4-thiazolidinone nucleus have occupied a
unique place in the ﬁeld of medicinal chemistry [1]. They dis-
play a wide range of biological activities like antibacterial [2],9448824075; fax: +91 824
(B. Kalluraya).
Production and hosting by
o University.
lsevieranti-inﬂammatory [3] and anticancer [4]. They also have
nteresting activity proﬁles like serine/threonine-protein kinase
(PlK1) [5], cystic ﬁbrosis transmembrane conductance regula-
tor (CFTR) inhibitors [6].
Compounds containing quinolinemotif aremost widely used
as bio active agents [7,8]. Its derivative tetrazolo[1,5-a]quinoline
is a promising scaffold and is described as cytotoxic, dual non-
acidic anti-inﬂammatory, antimicrobial agent [9,10] and even
recognized as inhibitor of hepatitis C virus (HCV) [11].
Microwave (MW) irradiation, an unconventional energy
source, has been used for a variety of applications including
organic synthesis, wherein chemical reactions are accelerated
because of selective absorption of MW energy. The application
of microwave irradiation in conjunction with the use of cata-
lysts or mineral-supported reagents, under solvent-free condi-
tions, enables organic reactions to occur expeditiously at
ambient pressure, thus providing unique chemical processes
with special attributes such as enhanced reaction rates and
higher yields [12,13].
326 A. Adhikari et al.Prompted by these observation and in continuation of our
workonbiologically potent heterocycles [14,15]weherein report
the synthesis and biological activity of a series of 5-{[(6-substi-
tuted-2-hydroxyquinolin-3-yl)methylidene]/[(7-substitutedtet-
razolo[1,5-a]quinoline-4-yl)methylidine]}-2-[(4-substituted phe-
nyl)amino]-1,3-thiazol-4(5H)-one under solvent free conditions
using microwave energy.
Experimental
Instruments and starting materials
Purity of the newly synthesized compounds was checked by
TLC on silica gel plates (Merck, Silica gel 60F254). Melting
points were determined in open capillary tubes and are uncor-
rected. Elemental analysis was carried out in Vario EL III Ele-
menta model. IR spectra were recorded by dispersing the
compounds in KBr pellets on a Schimadzu FT-IR 157 spectro-
photometer. 1H NMR spectra were recorded on a Bruker
Avance II 400 MHz NMR spectrometer and all the chemical
shift values were reported as d (ppm). 13C NMR spectra were
recorded on a Bruker Avance II 400 MHz NMR spectrometer.
Mass spectra were recorded on a Agilent 6320 ion trap LC/MS
instrument. Microwave reactions were carried out in Godrej
(GMC 20E 08 SSGX, 800 Watt, 2450 MHz) microwave oven.
The synthetic route for the title compounds is outlined in
Schemes 1 and 2. 7-Substituted tetrazolo[1,5-a]quinoline-4-
carbaldehyde (3a–c) and 6-substituted-2-hydroxyquinoline-3-
carbaldehyde (4a–c) were prepared by reacting 6-substituted-
2-chloro quinoline-3-carbaldehyde (2) with sodium azide in
DMF/4 M HCl under microwave irradiation. 2-[(4-Substitut-
edphenyl) amino]-1,3-thiazol-4(5H)-one (1a–b) was prepared
by the reaction of substituted phenylthiourea with monochlo-
roaceticacid in presence of sodium acetate [16]. Reaction of
3a–c/4a–c with 1a–b gave the title compounds 5-[(6-substi-
tuted-2-hydroxyquinolin-3-yl)methylidene]-2-[(4-substitutedphe-
nyl)amino]-1, 3-thiazol-4(5H)-one/5-[(7-substitutedtetrazolo[1,
5-a]quinoline-4-yl)methylidene]-2-[(4-substitutedphenyl)amino]-
1,3-thiazol-4(5H)-one in high yield.Scheme 1 Synthesis ofGeneral procedure for the synthesis of 2-aryamino-4-
thiazolidinones (1a–b)
A mixture of aryl thiourea (0.1 mol) and fused sodium acetate
(16.4 g, 0.2 mol) was taken in absolute alcohol (100 mL) and
reﬂuxed for 8 h. The excess of solvent was removed under re-
duced pressure. The contents were added to ice-cold water.
The precipitate so obtained was ﬁltered, washed with distilled
water and recrystallized from ethanol. The compounds pre-
pared according to this procedure are:
2-Phenylamino-4-thiazolidinone 1a : M.p. 178–179 C (Lit
[16] M.p. 179 C), yield 70%.
2-(4-Methyl)amino-4-thiazolidinone 1b : M.p. 178–180 C
(Lit [16] M.p. 180 C), yield 69%.Synthesis of substituted tetrazolo[1,5-a]quinoline-4-
carbaldehyde (3a–c)
In a 100 mL beaker, 6-substituted-2-chloro-3-formyl quino-
lines (2) (0.01 mol) was dissolved in DMF (20 mL) and cooled.
To the clear solution sodium azide (1.3 g, 0.02 mol) was added
and the contents were subjected to MW irradiation (90 W) for
3 min. As the beaker was allowed to cool, silky solid material
precipitates out. It was poured to crushed ice (100 g), ﬁltered,
dried and recrystallized from DMF.
Tetrazolo[1,5-a]quinoline-4-carbaldehyde 3a
M.p. 210 C; yield 80%. – 1H NMR (DMSO-d6) d: 7.912 (m,
1H, Ar–H), 8.15 (m, 1H, Ar–H), 8.47 (d, 1H, J= 7.92 Hz,
Ar–H), 8.72 (d, 1H, J= 8.4 Hz, Ar–H), 9.02 (s, 1H, Py–H),
10.43 (s, 1H, CHO); – LC/MS: m/z= 199 (M++1). –
C10H6N4O (198): calcd. C 60.60; H 3.05; N 28.27; found C
60.54; H 3.01; N 28.21.
7-Methyltetrazolo[1,5-a]quinoline-4-carbaldehyde 3b
M.p. 213 C; yield 82%. – 1H NMR (DMSO-d6) d: 2.31 (s, 3H,
CH3), 7.75 (s, 1H, Ar–H), 7.85 (d, 1H, J= 6.8 Hz, Ar–H),quinoline analogues.
Scheme 2 Synthesis of novel thiazolidinone derivatives.
Rapid synthesis of bioactive thiazolidinone analogues 3278.53 (d, 1H, J= 8.1 Hz, Ar–H), 9.12 (s, 1H, Py–H), 10.53 (s,
1H, CHO); – LC/MS: m/z= 213 (M++1). – C11H8N4O
(212): calcd. C 62.26; H 3.80; N 26.40; found C 62.19; H
3.71; N 26.33.
7-Methoxytetrazolo[1,5-a]quinoline-4-carbaldehyde 3c
M.p. 227 C; yield 84%. – 1H NMR (DMSO-d6) d: 3.95 (s, 3H,
OCH3), 7.68 (d, 1H, J= 6.92 Hz, Ar–H), 7.91 (s, 1H, Ar–H),
8.56 (d, 1H, J= 7.92 Hz, Ar–H), 9.31 (s, 1H, Py–H), 10.79 (s,
1H, CHO); – LC/MS: m/z= 229 (M++1). – C11H8N4O2
(228): calcd. C 57.89; H 3.53; N 24.55; found C 57.78; H
3.46; N 24.48.
General method for the preparation of 6-substituted-2-
hydroxyquinoline-3-carbaldehyde (4a–c)
In a 250 mL beaker, 6-substituted-2-chloro-3-formylquinolines
(2) (0.01 mol) and HCl (35 mL, 4 M) was taken and subjected
to MW irradiation (120 W) for 6 min. The contents were
cooled to r.t. and poured into a beaker containing crushed
ice (100 g), ﬁltered, dried and recrystallized from acetic acid.
2-Hydroxyquinoline-3-carbaldehyde 4a : M.p. 297 C (Lit
[17] M.p. 298 C).
6-Methyl-2-hydroxyquinoline-3-carbaldehyde 4b : M.p.
274 C (Lit [17] M.p. 275 C).
6-Methoxy-2-hydroxyquinoline-3-carbaldehyde 4c: M.p.
272 C (Lit [17] M.p. 274 C).
General procedure for the synthesis of 5-{[(6-substituted-2-
hydroxyquinolin-3-yl)methylidene]/[(7-substitutedtetrazolo-
[1,5-a]quinoline-4yl)methylidine]}-2-[(4-substituted
phenyl)amino]-1,3-thiazol-4(5H)-one
An equimolar mixture of 7-substituted tetrazolo[1,5-a]quino-
line-4-carbaldehyde (3a–c)/6-substituted-2-hydroxyquinoline-
3-carbaldehyde (4a–c) (0.01 mol), anhydrous sodium acetate(0.01 mol) and 2-[(4-substitutedphenyl)amino]-1,3-thiazol-
4(5H)-one (1a–b) (0.01 mol) was ground together in a mortar
using a pestle for uniform mixing. This mixture was taken in
a 50 mL beaker and subjected to MW irradiation (90 W).
The completion of the reaction was monitored using TLC.
The product obtained was poured into crushed ice, ﬁltered,
washed with ethanol and recrystallized from DMF to give
compounds 5a–f and 6a–f.
5-[(Tetrazolo[1,5-a]quinoline-4yl)methylidine]-2-(phenyl-
amino)-1,3-thiazol-4(5H)-one 5a
R=H, R1 = H; M.p. 275 C; yield 93%. – IR (KBr):
m= 2983.6 (CAH), 1650.9 (C‚O), 1514.6 (C‚N) cm1. –
1H NMR (DMSO-d6): d= 7.11–8.64 (m, 10H, Ar–H), 11.84
(br, 1H, NH), 12.68 (s, 1H, CH‚C). – LC–MS: m/z
(%) = 373 (M++1). – C19H12N6OS (372): calcd. C 61.28;
H 3.25; N 22.57; S 8.61; found C 61.19; H 3.16; N 22.51; S
8.57.
5-[(Tetrazolo[1,5-a]quinoline-4yl)methylidine]-2-[(4-methyl-
phenyl)amino]-1,3-thiazol-4(5H)-one 5b
R1 = H, R= CH3; M.p. 268 C; yield 90%. – IR (KBr):
m= 2969.5 (CAH), 1655.2 (C‚O), 1525.7 (C‚N) cm1. –
1H NMR (DMSO-d6): d= 2.32 (s, 3H, CH3), 7.16–8.59 (m,
9H, Ar–H), 11.8 (br, 1H, NH), 12.53 (s, 1H, CH‚C). – LC–
MS: m/z (%) = 387 (M++1). – C20H14N6OS (386): calcd. C
62.16; H 3.65; N 21.75; S 8.30; found C 62.10; H 3.59; N
21.69; S 8.25.
5-[(7-Methyl-tetrazolo[1,5-a]quinoline-4yl)methylidine]-2-
(phenylamino)-1,3-thiazol-4(5H)-one 5c
R1 = CH3, R = H; M.p. 280 C; yield 91%. – IR (KBr):
m= 2975.1 (CAH), 1661.5 (C‚O), 1531.3 (C‚N) cm1. –
1H NMR (DMSO-d6): d= 2.32 (s, 3H, CH3), 7.14–8.61 (m,
9H, Ar–H), 11.78 (br, 1H, NH), 12.61 (s, 1H, CH‚C). –
LC–MS: m/z (%) = 387 (M++1). – C20H14N6OS (386):
calcd. C 62.16; H 3.65; N 21.75; S 8.30; found C 62.12; H
3.56; N 21.67; S 8.22.
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[(4-methylphenyl)amino]-1,3-thiazol-4(5H)-one 5d
R1 = CH3, R = CH3; M.p. 278 C; yield 89%. – IR (KBr):
m= 2985.4 (CAH), 1659.3 (C‚O), 1528.5 (C‚N) cm1. –
1H NMR (DMSO-d6): d= 2.31 (s, 3H, CH3), 2.32 (s, 3H,
CH3), 7.13–8.59 (m, 8H, Ar–H), 11.81 (br, 1H, NH), 12.68
(s, 1H, CH‚C). – LC–MS: m/z (%) = 401 (M++1). –
C21H16N6OS (400): calcd. C 62.98; H 4.03; N 20.99; S 8.01;
found C 62.86; H 3.98; N 20.91; S 7.95.
5-[(7-Methoxy-tetrazolo[1,5-a]quinoline-4yl)methylidine]-2-
(phenylamino)-1,3-thiazol-4(5H)-one 5e
R1 = OCH3, R = H; M.p. 286 C; yield 94%. – IR (KBr):
m= 2935.6 (CAH), 1657.2 (C‚O), 1532.4 (C‚N) cm1. –
1H NMR (DMSO-d6): d 3.97 (s, 3H, OCH3), 7.11–8.55 (m,
9H, Ar–H), 11.76 (br, 1H, NH), 12.65 (s, 1H, CH‚C). –
LC–MS: m/z (%) = 402.9 (M++1). – C20H14N6O2S (402):
calcd. C 59.69; H 3.51; N 20.88; S 7.97; found C 59.59; H
3.46; N 20.78; S 7.86.
5-[(7-Methoxy-tetrazolo[1,5-a]quinoline-4yl)methylidine]-2-
[(4-methylphenyl)amino]-1,3-thiazol-4(5H)-one 5f
R1 = OCH3, R = CH3; M.p. 289 C; yield 93%. – IR (KBr):
m= 2920.1 (CAH), 1686.1 (C‚O), 1506.8 (C‚N) cm1. – 1H
NMR (DMSO-d6): d 2.32 (s, 3H, CH3), 3.98 (s, 3H, OCH3),
7.26–8.57 (m, 8H, Ar–H), 11.75 (br, 1H, NH), 12.69 (s, 1H,
CH‚C). – LC–MS: m/z (%) = 415.0 (M+-1). – C21H16N6O2S
(416): calcd. C 60.56; H 3.87; N 20.18; S 7.70; found C 60.49; H
3.81; N 20.12; S 7.61.
5-[(2-Hydroxyquinolin-3-yl)methylidene]-2-(phenylamino)-
1,3-thiazol-4(5H)-one 6a
R1 = H, R = H; M.p. 301 C; yield 93%. – IR (KBr):
m= 3211.4 (OAH), 2960.7 (CAH), 1661.3 (C‚O), 1520.8
(C‚N) cm1. – 1H NMR (DMSO-d6): d= 7.06–8.15 (m,
10H, Ar–H), 11.56 (br, 1H, NH), 12.17 (s, 1H, CH‚C),
12.4 (br, 1H, OH). – 13C NMR (DMSO-d6): d= 115.14,
120.57, 122.45, 122.59, 125.16, 128.87, 129.21, 129.52, 131.81,
138.8, 139.86, 140.4, 160.84. – LC–MS: m/z (%) = 348
(M++1). – C19H13N3O2S (347): calcd. C 65.69; H 3.77; N
12.10; S 9.23; found C 65.61; H 3.69; N 12.01; S 9.17.
5-[(2-Hydroxyquinolin-3-yl)methylidene]-2-[(4-
methylphenyl)amino]-1,3-thiazol-4(5H)-one 6b
R1 = H, R= CH3; M.p. 299 C; yield 86%. – IR (KBr):
m= 3221.5 (OAH), 2959.8 (CAH), 1652.8 (C‚O), 1524.6
(C‚N) cm1. – 1H NMR (DMSO-d6): d= 2.32 (s, 3H,
CH3), 7.05–8.2 (m, 9H, Ar–H), 11.51 (br, 1H, NH), 12.11 (s,
1H, CH‚C), 12.36 (br, 1H, OH). – LC–MS: m/z (%) = 362
(M++1). – C20H15N3O2S (361): calcd. C 66.46; H 4.18; N
11.63; S,8.87; found C 66.38; H 4.11; N 11.9; S 8.80.
5-[(6-Methyl-2-hydroxyquinolin-3-yl)methylidene]-2-(4-
phenylamino)-1,3-thiazol-4(5H)-one 6c
R1 = CH3, R = H; M.p. 304 C; yield 89%. – IR (KBr):
m= 3159.3 (OAH), 3001.1 (CAH), 1669.1 (C‚O), 1510.4
(C‚N) cm1. – 1H NMR (DMSO-d6): d= 2.36 (s, 3H,
CH3), 7.07–8.08 (m, 9H, Ar–H), 11.54 (br, 1H, NH), 12.10
(s, 1H, CH‚C), 12.37 (br, 1H, OH). – LC–MS: m/z
(%) = 362 (M++1). – C20H15N3O2S (361): calcd. C 66.46;H 4.18; N 11.63; S,8.87; found C 66.39; H 4.11; N 11.59; S
8.79.
5-[(6-Methyl-2-hydroxyquinolin-3-yl)methylidene]-2-[(4-
methylphenyl)amino]-1,3-thiazol-4(5H)-one 6d
R1 = CH3, R = CH3; M.p. 306 C; yield 92%. – IR (KBr):
m= 3169.3 (OAH), 2985.4 (CAH), 1659.3 (C‚O), 1528.5
(C‚N) cm1. – 1H NMR (DMSO-d6): d= 2.31 (s, 3H,
CH3), 2.32 (s, 3H, CH3), 7.03–8.10 (m, 8H, Ar–H), 11.57
(br, 1H, NH), 12.14 (s, 1H, CH‚C), 12.34 (br, 1H, OH). –
LC–MS: m/z (%) = 376 (M++1). – C21H17N3O2S (375):
calcd. C 67.18; H 4.56; N 11.19; S 8.54; found C 67.10; H
4.51; N 11.10; S 8.48.
5-[(6-Methoxy-2-hydroxyquinolin-3-yl)methylidene]-2-
(phenylamino)-1,3-thiazol-4(5H)-one 6e
R1 = OCH3, R = H; M.p. 307 C; yield 95%. – IR (KBr):
m= 3149.3 (OAH), 2962.7 (CAH), 1671.2 (C‚O), 1518.7
(C‚N) cm1. – 1H NMR (DMSO-d6): d 3.98 (s, 3H,
OCH3), 7.07–8.17 (m, 9H, Ar–H), 11.52 (br, 1H, NH), 12.17
(s, 1H, CH‚C), 12.35 (br, 1H, OAH). – LC–MS: m/z
(%) = 378 (M++1). – C20H15N3O3S (377): calcd. C 63.65;
H 4.01; N 11.13; S 8.50; found C 63.57; H 3.97; N 11.08; S
8.43.
5-[(6-Methoxy-2-hydroxyquinolin-3-yl)methylidene]-2-[(4-
methylphenyl)amino]-1,3-thiazol-4(5H)-one 6f
R1 = OCH3, R = CH3; M.p. 310 C; yield 92%. – IR (KBr):
m= 3224.7 (OAH), 2928.6 (CAH), 1659.7 (C‚O), 1516.3
(C‚N) cm1. – 1H NMR (DMSO-d6): d 2.31 (s, 3H, CH3),
3.97 (s, 3H, OCH3), 7.06–8.15 (m, 8H, Ar–H), 11.48 (br, 1H,
NH), 12.09 (s, 1H, CH‚C), 12.31 (br, 1H, OH). – LC–MS:
m/z (%) = 392 (M++1). – C21H17N3O3S (391): calcd. C
64.43; H 4.38; N 10.73; S 8.19; found C 64.39; H 4.31; N
10.65; S 8.11.
Biological evaluations
DPPH radical scavenging activity
The procedure of Brand-Williams et al. [18] was followed for
evaluation of the free radical-scavenging capacity. Brieﬂy,
1 mL of the test sample (100 lg/mL) was mixed with the meth-
anolic 2,2-diphenyl-1-picrylhydrazyl (DPPH) solution (2 mL,
0.2 mM). The absorbance was measured at 517 nm immedi-
ately after standing at room temperature for 30 min. The per-
centage of scavenging has been calculated as the ratio of the
absorption of the sample relative to the control DPPH
(0.2 mM) solution without the test samples. DPPH radical-
scavenging activity was expressed as the inhibition percentage.
Results are shown in Table 1.
Antibacterial activity
The newly synthesized compounds were screened for their anti-
bacterial activity againstEscherichia coli, Staphylococcus aureus
and Pseudomonas aeruginosa using Agar well diffusion method
[19]. In this method, 24 h old Muller–Hinton broth cultures of
test bacteria were swabbed uniformly on solidiﬁed sterile
Muller–Hinton agar plates using sterile cotton swab. Then,
Table 1 DPPH radical scavenging assay for the compounds
5a–f/6a–f.
Compd No. % Inhibition at 100 lg/mL ± SEMa
5a 78.5 ± 0.64
5b 76.5 ± 0.58
5c 89.0 ± 0.66
5d 79.6 ± 0.52
5e 79.1 ± 0.66
5f 82.1 ± 0.74
6a 80.2 ± 0.68
6b 82.0 ± 0.72
6c 92.1 ± 0.86
6d 81.7 ± 0.71
6e 84.5 ± 0.84
6f 83.1 ± 0.76
BHT 91.3 ± 1.11
a Data represents mean ± S.E.M. of triplicate analysis.
Rapid synthesis of bioactive thiazolidinone analogues 329aseptically wells of 6 mm diameter were bored in the inoculated
plates with the help of gel puncher and the samples (100 lL),
standard (Amoxicillin, 100 lL) and control (DMSO) were
added into the labelled wells. The plates were incubated at
37 C for 24 h in upright position and the zone of inhibition
was recorded. Experiments were done at concentrations of 100
and 50 lg/mL of the test samples. The results are summarized
in Table 2.Antifungal activity
The antifungal activity was carried out against the fungi Can-
dida albicans, Aspergillus ﬂavus by agar well diffusion method
[20]. The cultures of 48 h old grown on potato dextrose agar
(PDA) were used for inoculation of fungal strain on PDA
plates. An aliquot (0.02 ml) of inoculum was introduced to
molten PDA and poured into a petri dish. After solidiﬁca-
tion, the appropriate wells were made on agar plate by using
cork borer. Incubation period of 24–48 h at 28 C was main-
tained for observation of antifungal activity of the com-
pounds. The antifungal activity was evaluated by measuringTable 2 Antibacterial and antifungal activity of compounds 5a–f/6
Compd.
E. coli P. aeruginosa
5a 16.5 ± 2.6 19.0 ± 2.6
5b 18.0 ± 2.8 36.5 ± 3.4
5c 24.5 ± 3.2 38.0 ± 3.2
5d 18.5 ± 2.4 17.5 ± 2.8
5e 17.0 ± 2.2 15.5 ± 2.4
5f 14.5 ± 1.6 17.0 ± 1.8
6a 19.0 ± 1.8 15.0 ± 2.8
6b 16.5 ± 2.0 14.5 ± 2.2
6c 38.0 ± 3.8 12.5 ± 1.8
6d 34.5 ± 3.6 14.0 ± 2.4
6e 14.0 ± 1.6 18.5 ± 2.6
6f 15.5 ± 1.8 19.0 ± 2.2
Standard 8.5 ± 0.5 10.1 ± 1.2
Control 0 0
a Data represents mean ± S.E.M. of triplicate analysis.zones of inhibition of fungal growth. Metronidazole was used
as standard. The complete antifungal analysis was carried out
under strict aseptic conditions. The results are summarized in
Table 2.
Determination of minimum inhibitory concentrations (MICs)
A serial dilution was carried out to give ﬁnal concentrations
between 1.5 and 50.00 lg/mL of the test samples. The tubes
were inoculated with 20 lL of the bacterial suspension per
mL nutrient broth, homogenized and incubated at 37 C.
The MIC value was determined as the lowest concentration
of the test samples in the broth medium that inhibited the vis-
ible growth of the test microorganism [21].
Statistical analysis
The results of these experiments were expressed as
mean ± S.E. of six animals in each group. The data were eval-
uated by one way analysis of variance (ezANOVA) followed
by Tukey’s pair-wise comparison test. The values of
P< 0.05 and P< 0.01 were considered as statistically
signiﬁcant.
Results and discussion
Chemistry
The current investigation describes the convenient synthesis of
starting compounds 7-substituted tetrazolo[1,5-a]quinoline-
4-carbaldehyde (3a–c) and 6-substituted-2-hydroxyquinoline-
3-carbaldehyde (4a–c) under microwave energy in high yield.
Also when these were subjected to react with 2-[(4-substituted-
phenyl)amino]-1,3-thiazol-4(5H)-one (1a–b) under solvent free
conditions using microwave energy, successfully yielded 5-[(6-
substituted-2-hydroxyquinolin-3-yl)methylidene]-2-[(4-substitut-
edphenyl)amino]-1,3-thiazol-4(5H)-one (5a–f) and 5-[(7-substi-
tutedtetrazolo[1,5-a]quinoline-4-yl)methylidene]-2-[(4-substituted-
phenyl)amino]-1,3-thiazol-4(5H)-one (6a–f) in short time. Thisa–f.
MIC lg/mLa
S. aureus C. albicans A. ﬂavus
37.5 ± 2.8 16.0 ± 1.8 19.0 ± 2.2
36.0 ± 3.1 19.5 ± 2.6 20.0 ± 2.0
38.0 ± 2.6 34.0 ± 3.2 40.0 ± 4.1
21.0 ± 2.2 12.6 ± 1.8 19.5 ± 2.2
19.5 ± 2.1 18.0 ± 2.0 38.5 ± 4.2
32.0 ± 2.8 14.0 ± 2.6 18.5 ± 2.4
32.5 ± 2.6 19.0 ± 2.2 20.5 ± 2.8
36.5 ± 2.8 16.5 ± 1.6 19.5 ± 2.4
38.0 ± 3.2 38.5 ± 3.8 38.0 ± 4.1
36.0 ± 3.4 19.0 ± 1.8 38.6 ± 3.6
32.5 ± 2.8 16.5 ± 2.2 22.0 ± 2.8
34.0 ± 3.1 36.5 ± 3.6 32.5 ± 3.2
12.0 ± 1.6 10.5 ± 1.6 14.5 ± 2.2
0 0 0
330 A. Adhikari et al.method is unique, rapid and convenient for the synthesis of
novel compounds.
Pharmacology
Test samples 5a–f/6a–f were screened for their free radical
scavenging activity by DPPH method. Antioxidant reacts with
DPPH, which is a stable free radical and converts it to
1,1-diphenyl-2-picrylhydrazine. The degree of discoloration
indicates the scavenging potentials of the antioxidant com-
pounds. At the concentration of 100 lg, compounds 5c and
6c display the highest activity which is comparable with the
standard butylated hydroxytoluene (BHT).
During the antibacterial and antifungal screening of the
compound 5a–f/6a–f strict aseptic conditions were followed.
Among the compounds tested 5f and 6e showed good antibac-
terial activity where as compound 5a, 5d, 5f and 6b displayed
good antifungal activity at 100 lg/mL. All the results are pre-
sented in Table 2.
Conclusion
Synthesis of heterocyclic compounds like thiazolidinones and
their derivatives generally involve prolonged reaction condi-
tions. So herein we report amicrowavemediated green synthesis
of the title compounds in good yield. Also antioxidant results
justify the use of compound 5a–f/6a–f as efﬁcient radical scav-
engers as all the compounds demonstrate signiﬁcant activity.
Among them compound 5c and 6c displayed highest activity
which is equivalent to the standard. Apart from that some of
the compounds also displayed signiﬁcant antibacterial and anti-
fungal activity. Thus on the basis of these results it can be con-
cluded that the compounds bearing thiazolidinones along with
tetrazol[1,5-a]quinoline/hydroxylquinolines constitute novel
bio molecules of signiﬁcant pharmacological importance.Acknowledgement
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